Oncology: Oncologists Lack Info To Prepare For The Worst
Docs won't know details of looming treatment cuts until late this year.The suspense is killing oncologists. So far, the Centers for Medicare & Medicaid Services has released incomplete and out-of-date information on the fate of a thousand cuts it will to deal to cancer treatments next year. For one thing, CMS included first-quarter numbers for average sales price, according to Deborah Kamin, senior director of cancer policy and clinical affairs with the American Society for Clinical Oncology (ASCO). The actual payment rates for oncology drugs will be based on 106 percent of third-quarter ASP numbers, not first-quarter numbers...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: